文献速递炎症性肠病

炎症性肠病患者心肌炎长期风险:瑞典全国队列研究

Long-Term Risk of Myocarditis in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study in Sweden.
PubMed 文献 · Am J Gastroenterol · 2024-02-05

该瑞典全国队列纳入1969-2017年活检确诊的炎症性肠病(IBD)患者83,264例、一般人群参照个体391,344例及无IBD同胞96,149例,随访至2019年。中位随访12年,IBD患者心肌炎发生率为22.6/10万人年,参照个体为12.9,调整后风险比(aHR)1.55(95%CI 1.33-1.81),风险持续至诊断后20年;严重心肌炎aHR为2.44(95%CI 1.89-3.15)。绝对风险较低。

要点

  • IBD患者心肌炎长期风险增加,aHR 1.55,持续至诊断后20年。
  • 严重心肌炎风险更高,aHR 2.44,且各IBD亚型均一致。
  • 绝对风险低,至20年每735例IBD患者仅多1例心肌炎。

核心结论

  • IBD患者心肌炎风险增加,尤其是严重心肌炎,持续至少20年,但绝对风险低。

研究设计与样本

  • 瑞典全国队列研究,纳入1969-2017年活检确诊IBD患者83,264例(CD 24,738例、UC 46,409例、IBD-U 12,117例)、一般人群参照个体391,344例及无IBD同胞96,149例,随访至2019年。
  • 采用灵活参数生存模型估计调整后风险比(aHR)和累积发病率,并提供95%置信区间。

主要发现

  • 中位随访12年,IBD患者心肌炎发生率为22.6/100,000人年,参照个体为12.9/100,000人年,aHR 1.55(95%CI 1.33-1.81)。
  • 风险持续至IBD诊断后20年,相当于至20年每735例IBD患者多1例心肌炎。
  • CD患者aHR 1.48(95%CI 1.11-1.97),UC患者aHR 1.58(95%CI 1.30-1.93)。
  • 严重心肌炎发生率IBD组10.1/100,000人年 vs 参照组3.5/100,000人年,aHR 2.44(95%CI 1.89-3.15);CD aHR 2.39(95%CI 1.43-4.01),UC aHR 2.82(95%CI 1.99-4.00),IBD-U aHR 3.14(95%CI 1.55-6.33)。
  • 同胞比较分析结果相似。

临床怎么用

  • 对IBD患者应关注心肌炎相关症状,尤其是严重心肌炎,长期随访中保持警惕。
  • 尽管绝对风险低,但风险持续20年,临床评估心血管症状时需考虑IBD病史。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Despite a suggested link between inflammatory bowel disease (IBD) and myocarditis, the association has not been well established. This study aimed to investigate the long-term risk of myocarditis in patients with IBD. METHODS: This nationwide cohort involved all patients with biopsy-confirmed IBD in Sweden (1969-2017) (n = 83,264, Crohn's disease [CD, n = 24,738], ulcerative colitis [UC, n = 46,409], and IBD-unclassified [IBD-U, n = 12,117]), general population reference individuals (n = 391,344), and IBD-free full siblings (n = 96,149) and followed until 2019. Primary outcome was incident myocarditis, and secondary outcome was severe myocarditis (complicated with heart failure, death, or readmission). Flexible parametric survival models were used to estimate adjusted hazard ratios (aHRs) and cumulative incidence of outcomes, along with 95% confidence intervals. RESULTS: During a median follow-up of 12 years, there were 256 myocarditis cases in patients with IBD (incidence rate [IR] = 22.6/100,000 person-years) and 710 in reference individuals (IR = 12.9), with an aHR of 1.55 (95% confidence interval 1.33-1.81). The increased risk persisted through 20 years after IBD diagnosis, corresponding to 1 extra myocarditis case in 735 patients with IBD until then. This increased risk was observed in CD (aHR = 1.48 [1.11-1.97]) and UC (aHR = 1.58 [1.30-1.93]). IBD was also associated with severe myocarditis (IR: 10.1 vs 3.5; aHR = 2.44 [1.89-3.15]), irrespective of IBD subtypes (CD: aHR = 2.39 [1.43-4.01], UC: aHR = 2.82 [1.99-4.00], and IBD-U: aHR = 3.14 [1.55-6.33]). Sibling comparison analyses yielded similar results. DISCUSSION: Patients with IBD had an increased risk of myocarditis, especially severe myocarditis, for ≥20 years after diagnosis, but absolute risks were low.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Sun J, Yao J, Olén O, et al. Long-Term Risk of Myocarditis in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study in Sweden. Am J Gastroenterol. 2024. PMID: 38315442. doi:10.14309/ajg.0000000000002701

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。